Real World Clinical Outcomes for Metastatic Non-Small Cell Lung Cancer (mNSCLC) at IRST Italy

被引：0
|
作者：
Altini, M. [1 ]
Massa, I. [1 ]
Balzi, W. [1 ]
Gentili, N. [1 ]
Foca, F. [1 ]
Danesi, V. [1 ]
Manunta, S. [1 ]
Ejzykowicz, F. [2 ]
Chandwani, S. [3 ]
Burgio, M. [1 ]
Cravero, P. [1 ]
Verlicchi, A. [1 ]
Bronte, G. [1 ]
Crino, L. [1 ]
Delmonte, A. [1 ]
机构：
[1] IRCCS, Ist Sci Romagnolo Studio & Cura Tumor Irst, Meldola, Italy
[2] Merck & Co Inc, Oncol Prod Line, Core, Kenilworth, NJ USA
[3] Merck & Co Inc, Ctr Observat & Real World Evidence, Kenilworth, NJ USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
treatment pattern; real-world study; Outcomes;
D O I：
10.1016/j.jtho.2019.08.2369
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.16-04
引用
收藏
页码：S1065 / S1066
页数：2
相关论文
共 50 条
  • [21] Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status Abstract
    Kerrigan, Kathleen
    Wang, Xuechen
    Haaland, Benjamin
    Adamson, Blythe
    Patel, Shiven
    Puri, Sonam
    Akerley, Wallace
    CLINICAL LUNG CANCER, 2021, 22 (04) : 260 - +
  • [22] Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study
    Hochmair, Maximilian
    Terbuch, Angelika
    Lang, David
    Trockenbacher, Christian
    Augustin, Florian
    Ghanim, Bahil
    Maurer, Dominik
    Taghizadeh, Hossein
    Kamhuber, Christoph
    Wurm, Robert
    Lindenmann, Joerg
    Braz, Petra
    Bundalo, Tatjana
    Begic, Merjem
    Bauer, Johanna
    Reimann, Patrick
    Mueser, Nino
    Huemer, Florian
    Schlintl, Verena
    Bianconi, Daniela
    Baumgartner, Bernhard
    Schenk, Peter
    Rauter, Markus
    Hoetzenecker, Konrad
    CANCERS, 2024, 16 (14)
  • [23] Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer Database
    Bates, James E.
    Morris, Christopher G.
    Milano, Michael T.
    Yeung, Anamaria R.
    Hoppe, Bradford S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 138 : 75 - 79
  • [24] Adjuvant Chemotherapy for Non-Small Cell Lung Cancer
    D'Amico, Thomas A.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2005, 17 (03) : 195 - 198
  • [25] Survival Implications of De Novo Versus Recurrent Metastatic Non-Small Cell Lung Cancer
    Moore, Sara
    Leung, Bonnie
    Wu, Jonn
    Ho, Cheryl
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (03): : 292 - 297
  • [26] Classifying Oligometastatic Non-Small Cell Lung Cancer
    Blumenthaler, Alisa N.
    Antonoff, Mara B.
    CANCERS, 2021, 13 (19)
  • [27] Racial and socioeconomic disparities in survival among patients with metastatic non-small cell lung cancer
    Uprety, Dipesh
    Seaton, Randell
    Hadid, Tarik
    Mamdani, Hirva
    Sukari, Ammar
    Ruterbusch, Julie J.
    Schwartz, Ann G.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (10): : 1697 - 1704
  • [28] Thoracoscopic Lobectomy for Non-small Cell Lung Cancer
    Gaudet, Matthew A.
    D'Amico, Thomas A.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 503 - +
  • [29] Survival Outcomes of Salvage Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer
    Moore, S.
    Leung, B.
    Wu, J.
    Ho, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S628 - S629
  • [30] Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer
    Kazandjian, Dickran
    Gong, Yutao
    Keegan, Patricia
    Pazdur, Richard
    Blumenthal, Gideon M.
    JAMA ONCOLOGY, 2019, 5 (10) : 1481 - 1485
12345